Company / Capital Expenditures
CANNAPHARMARX, INC. Capital Expenditures History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$5.5K
FY2025
5-year range
$0 / $5.5K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $4,774 to $5,519 over the past 6 years.
Based on SEC 10-K filings.
$5,519 in FY2025 with a 10-year CAGR of +10.3%.
Improved from $4,774 to $5,519 over the past 6 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +10.3%
Key checks
Key Insights
- Lowest capital expenditures in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.5K | - |
| FY2024 | $0 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $4.8K | - |
| FY2018 | $0 | - |
| FY2017 | - | - |
| FY2016 | $0 | -100.0% |
| FY2015 | $2.1K | -97.9% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026